Colonization of methicillin-resistant Staphylococcus aureus (MRSA) allows people in the community to unknowingly harbor and spread this life-threatening bacteria. The inside of the front of the nose is where this bacteria is most predominant, but new research shows nearly all colonized individuals have this bacteria living in other body sites. The study was published in Infection Control and Hospital Epidemiology.
“While people colonized with MRSA may not be sick, the bacteria can become aggressive and lead to infection in the person or others,” says Kyle Popovich, MD, MS, lead author of the study.
Because of the risk of transmission, hospitals have developed infection control and prevention efforts that identify individuals with nasal MRSA colonization. These patients may be placed in isolation or decolonized of MRSA by treating and removing the bacteria from the patient’s nose and skin. These strategies have been used to prevent MRSA infections for the patient and to decrease risk of spread of MRSA to other patients. Several states also mandate these MRSA surveillance programs.
Researchers collected surveillance swab specimens for nose and other body sites from patients at Stroger Hospital of Cook County within 72 hours of admission from March 2011-April 2012. After analyzing the samples, researchers observed that, following the nose, the rectal and groin areas were frequent sites of colonization of community-associated MRSA. The bacteria were found in these body sites more often in men than women.
“Our findings show that MRSA colonization is not limited to the nose. This may have important implications MRSA surveillance programs nationwide,” says Popovich.
Reference: Kyle J. Popovich, Alla Aroutcheva, Bala Hota, Kathleen G. Beavis, Mary K. Hayden, Robert A. Weinstein. Anatomic Sites of Colonization with Community-Associated Methicillin-Resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology [35:9] (September 2014).
Source: Society for Healthcare Epidemiology of America (SHEA)
Expanded Screening Protocols Improve Early Detection of Candida auris at Mount Sinai Brooklyn
December 1st 2024Mount Sinai Brooklyn’s expanded Candida auris screening protocols identified more cases, enabling timely isolation and disinfection measures to prevent outbreaks and enhance patient safety in hospital settings.
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.